CVA Family Office’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $404K | Sell |
8,736
-733
| -8% | -$33.9K | 0.06% | 191 |
|
|
2025
Q1 | $578K | Buy |
9,469
+60
| +0.6% | +$3.66K | 0.09% | 146 |
|
|
2024
Q4 | $532K | Buy |
9,409
+685
| +8% | +$38.7K | 0.08% | 152 |
|
|
2024
Q3 | $451K | Buy |
8,724
+731
| +9% | +$37.8K | 0.07% | 161 |
|
|
2024
Q2 | $332K | Buy |
7,993
+1,229
| +18% | +$51K | 0.06% | 177 |
|
|
2024
Q1 | $367K | Buy |
6,764
+3,714
| +122% | +$201K | 0.07% | 176 |
|
|
2023
Q4 | $156K | Sell |
3,050
-507
| -14% | -$26K | 0.03% | 267 |
|
|
2023
Q3 | $206K | Sell |
3,557
-445
| -11% | -$25.8K | 0.05% | 216 |
|
|
2023
Q2 | $256K | Buy |
4,002
+45
| +1% | +$2.88K | 0.05% | 188 |
|
|
2023
Q1 | $274K | Sell |
3,957
-465
| -11% | -$32.2K | 0.06% | 180 |
|
|
2022
Q4 | $318K | Sell |
4,422
-307
| -6% | -$22.1K | 0.08% | 147 |
|
|
2022
Q3 | $336K | Sell |
4,729
-422
| -8% | -$30K | 0.09% | 129 |
|
|
2022
Q2 | $397K | Buy |
5,151
+252
| +5% | +$19.4K | 0.11% | 107 |
|
|
2022
Q1 | $358K | Buy |
4,899
+753
| +18% | +$55K | 0.09% | 123 |
|
|
2021
Q4 | $258K | Buy |
4,146
+2,343
| +130% | +$146K | 0.06% | 150 |
|
|
2021
Q3 | $109K | Sell |
1,803
-2,277
| -56% | -$138K | 0.08% | 118 |
|
|
2021
Q2 | $273K | Buy |
4,080
+927
| +29% | +$62K | 0.08% | 131 |
|
|
2021
Q1 | $199K | Buy |
3,153
+223
| +8% | +$14.1K | 0.08% | 120 |
|
|
2020
Q4 | $182K | Buy |
2,930
+1,127
| +63% | +$70K | 0.11% | 100 |
|
|
2020
Q3 | $109K | Buy |
1,803
+713
| +65% | +$43.1K | 0.08% | 118 |
|
|
2020
Q2 | $64K | Buy |
1,090
+590
| +118% | +$34.6K | 0.05% | 143 |
|
|
2020
Q1 | $28K | Buy |
+500
| New | +$28K | 0.03% | 178 |
|